Respiratory diseases – Value Added Medicines help improve therapy adherence to deliver better health outcomes for patients

Cardiovascular diseases – More patients are being treated while the sustainability of the healthcare system remains ensured

Covid policy paper 2022 – Lessons learned

Scientific advice for continuous innovation in known molecules

Medicines for Europe letter to EC on Divisionals & Patent Linkage re Fingolimod – 13.04.2022

Removing access barriers in Central and Eastern Europe – April 2022

Factsheet: The EU Bolar Exemption

Note on Transferable Vouchers – April 2022

Advancing Medicines repurposing in the EU

Repurposing has emerged as an important strategy to address unmet medical need. Yet, there is still significant untapped potential for its application in the EU.

 

Open

Creating a European ecosystem